FDFT1 and colorectal carcinoma: Mechanistically, fasting upregulated the level of FDFT1, which in turn resulted in the suppression of the AKT/mTOR/HIF1α pathway, thereby inhibiting CRC cell growth in response to FDFT1-inhibited glycolysiss [178].